Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention

Kraushaar LE, Krämer A (2009)
BMC Public Health 9(1): 64.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Kraushaar, Lutz E.; Krämer, AlexanderUniBi
Abstract / Bemerkung
Background: Cardiovascular and diabetic disease are the leading and preventable causes of death worldwide. The currently prognosticated dramatic increase in disease burden over the next two decades, however, bespeaks a low confidence in our prevention ability. This conflicts with the almost enthusiastic reporting of study results, which demonstrate substantial risk reductions secondary to simple lifestyle changes. Discussion: There is a case to be made for a disregard of the difference between statistical significance and clinical relevance of the reported data. Nevertheless, lifestyle change remains the main weapon in our battle against the epidemic of cardiometabolic disease. But along the way from risk screening to intervention to maintenance the compound inefficiencies of current primary preventive strategies marginalize their impact. Summary: Unless we dramatically change the ways in which we deploy preventive interventions we will inevitably lose the battle. In this paper we will argue for three provocative strategy changes, namely (a) the disbanding of screening in favor of population-wide enrollment into preventive interventions, (b) the substitution of the current cost utility analysis for a return-on-investment centered appraisal of interventions, and (c) the replacement of standardized programs modeled around acute care by individualized and perpetual interventions.
BMC Public Health
Page URI


Kraushaar LE, Krämer A. Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health. 2009;9(1):64.
Kraushaar, L. E., & Krämer, A. (2009). Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health, 9(1), 64.
Kraushaar, Lutz E., and Krämer, Alexander. 2009. “Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention”. BMC Public Health 9 (1): 64.
Kraushaar, L. E., and Krämer, A. (2009). Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health 9, 64.
Kraushaar, L.E., & Krämer, A., 2009. Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health, 9(1), p 64.
L.E. Kraushaar and A. Krämer, “Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention”, BMC Public Health, vol. 9, 2009, pp. 64.
Kraushaar, L.E., Krämer, A.: Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health. 9, 64 (2009).
Kraushaar, Lutz E., and Krämer, Alexander. “Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention”. BMC Public Health 9.1 (2009): 64.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Copyright Statement:
Dieses Objekt ist durch das Urheberrecht und/oder verwandte Schutzrechte geschützt. [...]
Access Level
OA Open Access
Zuletzt Hochgeladen
MD5 Prüfsumme

14 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Cardio-Metabolic Disease Risks and Their Associations with Circulating 25-Hydroxyvitamin D and Omega-3 Levels in South Asian and White Canadians.
Xiao CW, Wood CM, Swist E, Nagasaka R, Sarafin K, Gagnon C, Fernandez L, Faucher S, Wu HX, Kenney L, Ratnayake WM., PLoS One 11(1), 2016
PMID: 26809065
Willingness to participate in prevention programs for cardiometabolic diseases.
Petter J, Reitsma-van Rooijen MM, Korevaar JC, Nielen MM., BMC Public Health 15(), 2015
PMID: 25637105
Motivational interviewing and problem solving treatment to reduce type 2 diabetes and cardiovascular disease risk in real life: a randomized controlled trial.
Lakerveld J, Bot SD, Chinapaw MJ, van Tulder MW, Kostense PJ, Dekker JM, Nijpels G., Int J Behav Nutr Phys Act 10(), 2013
PMID: 23597082
CARRS Surveillance study: design and methods to assess burdens from multiple perspectives.
Nair M, Ali MK, Ajay VS, Shivashankar R, Mohan V, Pradeepa R, Deepa M, Khan HM, Kadir MM, Fatmi ZA, Reddy KS, Tandon N, Narayan KM, Prabhakaran D., BMC Public Health 12(), 2012
PMID: 22928740
Rate of neonatal weight gain and effects on adult metabolic health.
Kerkhof GF, Hokken-Koelega AC., Nat Rev Endocrinol 8(11), 2012
PMID: 22987159
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Lillie EO, Patay B, Diamant J, Issell B, Topol EJ, Schork NJ., Per Med 8(2), 2011
PMID: 21695041
Translational Behavioral Medicine: a pathway to better health.
Spring B., Transl Behav Med 1(1), 2011
PMID: 24073022
Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational study.
Rodríguez A, Calle A, Vázquez L, Chacón F, Polavieja P, Reviriego J, CADiNI Study Group., Diabet Med 28(6), 2011
PMID: 21294772
Impact and cost of a 2-week community-based screening and awareness program for diabetes and cardiovascular risk factors in a Swiss canton.
Bovet P, Hirsiger P, Emery F, De Bernardini J, Rossier C, Trebeljahr J, Hagon-Traub I., Diabetes Metab Syndr Obes 4(), 2011
PMID: 21760738

53 References

Daten bereitgestellt von Europe PubMed Central.

The Global Burden of Cardiovascular Disease
Ounpuu S, Anand S, Yusuf S., 2002

Primary prevention of diabetes mellitus.
Tuomilehto J, Wolf E., Diabetes Care 10(2), 1987
PMID: 3556107
Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association.
Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C, White RD., Diabetes Care 29(6), 2006
PMID: 16732040
Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline.
Rosenzweig JL, Ferrannini E, Grundy SM, Haffner SM, Heine RJ, Horton ES, Kawamori R; Endocrine Society., J. Clin. Endocrinol. Metab. 93(10), 2008
PMID: 18664543
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM; Diabetes Prevention Program Research Group., N. Engl. J. Med. 346(6), 2002
PMID: 11832527
Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.
Kosaka K, Noda M, Kuzuya T., Diabetes Res. Clin. Pract. 67(2), 2005
PMID: 15649575
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV., Diabetes Care 20(4), 1997
PMID: 9096977
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group., N. Engl. J. Med. 344(18), 2001
PMID: 11333990
The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity.
Lindstrom J, Louheranta A, Mannelin M, Rastas M, Salminen V, Eriksson J, Uusitupa M, Tuomilehto J; Finnish Diabetes Prevention Study Group., Diabetes Care 26(12), 2003
PMID: 14633807
Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
Ratner R, Goldberg R, Haffner S, Marcovina S, Orchard T, Fowler S, Temprosa M; Diabetes Prevention Program Research Group., Diabetes Care 28(4), 2005
PMID: 15793191
Glucose turnover and intima media thickness of internal carotid artery in type 2 diabetes offspring.
Anderwald C, Pfeiler G, Nowotny P, Anderwald-Stadler M, Krebs M, Bischof MG, Kozakova M, Luger A, Pacini G, Roden M, Waldhausl W., Eur. J. Clin. Invest. 38(4), 2008
PMID: 18339003
Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease.
Goldfine AB, Bouche C, Parker RA, Kim C, Kerivan A, Soeldner JS, Martin BC, Warram JH, Kahn CR., Proc. Natl. Acad. Sci. U.S.A. 100(5), 2003
PMID: 12591951
The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study.
McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G., Diabetes Care 28(2), 2005
PMID: 15677797
Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
Wannamethee SG, Shaper AG, Lennon L, Morris RW., Arch. Intern. Med. 165(22), 2005
PMID: 16344423
Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes.
Eddy DM, Schlessinger L, Kahn R., Ann. Intern. Med. 143(4), 2005
PMID: 16103469
Screening for type 2 diabetes mellitus in adults: recommendations and rationale.
U.S. Preventive Services Task Force., Ann. Intern. Med. 138(3), 2003
PMID: 12558361
National level promotion of physical activity: results from England's ACTIVE for LIFE campaign.
Hillsdon M, Cavill N, Nanchahal K, Diamond A, White IR., J Epidemiol Community Health 55(10), 2001
PMID: 11553661
Adherence to exercise programmes. Recommendations.
Robison JI, Rogers MA., Sports Med 17(1), 1994
PMID: 8153498
Enhancing adherence in clinical exercise trials
O'Neil HA, Blair SN., 2001
Successful weight loss maintenance.
Wing RR, Hill JO., Annu. Rev. Nutr. 21(), 2001
PMID: 11375440
High-risk individuals' willingness to pay for diabetes risk-reduction programs.
Johnson FR, Manjunath R, Mansfield CA, Clayton LJ, Hoerger TJ, Zhang P., Diabetes Care 29(6), 2006
PMID: 16732020

Drug metabolism and variability among patients in drug response.
Wilkinson GR., N. Engl. J. Med. 352(21), 2005
PMID: 15917386
Mitochondrial DNA sequence polymorphism, VO2max, and response to endurance training.
Dionne FT, Turcotte L, Thibault MC, Boulay MR, Skinner JS, Bouchard C., Med Sci Sports Exerc 25(7), 1993
PMID: 8350696
Individual differences in the responses to endurance and resistance training.
Hautala AJ, Kiviniemi AM, Makikallio TH, Kinnunen H, Nissila S, Huikuri HV, Tulppo MP., Eur. J. Appl. Physiol. 96(5), 2005
PMID: 16369817
A dietary approach to prevent hypertension: a review of the Dietary Approaches to Stop Hypertension (DASH) Study.
Sacks FM, Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N., Clin Cardiol 22(7 Suppl), 1999
PMID: 10410299
The metabolically healthy but obese individual presents a favorable inflammation profile.
Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, Rabasa-Lhoret R., J. Clin. Endocrinol. Metab. 90(7), 2005
PMID: 15855252
Metabolic and body composition factors in subgroups of obesity: what do we know?
Karelis AD, St-Pierre DH, Conus F, Rabasa-Lhoret R, Poehlman ET., J. Clin. Endocrinol. Metab. 89(6), 2004
PMID: 15181025
Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program.
Hernan WH, Brandle M, Zhang P, Williamson DF, Matulik MJ, Ratner RE, Lachin JM, Engelgau MM; Diabetes Prevention Program Research Group., Diabetes Care 26(1), 2003
PMID: 12502656
The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance.
Herman WH, Hoerger TJ, Brandle M, Hicks K, Sorensen S, Zhang P, Hamman RF, Ackermann RT, Engelgau MM, Ratner RE; Diabetes Prevention Program Research Group., Ann. Intern. Med. 142(5), 2005
PMID: 15738451
Health at a Glance: OECD Indicators 2005
Physical activity and coronary heart disease in men: The Harvard Alumni Health Study.
Sesso HD, Paffenbarger RS Jr, Lee IM., Circulation 102(9), 2000
PMID: 10961960
A meta-analysis of physical activity in the prevention of coronary heart disease.
Berlin JA, Colditz GA., Am. J. Epidemiol. 132(4), 1990
PMID: 2144946
The Medi-RIVAGE study: reduction of cardiovascular disease risk factors after a 3-mo intervention with a Mediterranean-type diet or a low-fat diet.
Vincent-Baudry S, Defoort C, Gerber M, Bernard MC, Verger P, Helal O, Portugal H, Planells R, Grolier P, Amiot-Carlin MJ, Vague P, Lairon D., Am. J. Clin. Nutr. 82(5), 2005
PMID: 16280426
Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle.
Forman D, Bulwer BE., Curr Treat Options Cardiovasc Med 8(1), 2006
PMID: 16401383
Primary prevention of stroke by healthy lifestyle.
Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB., Circulation 118(9), 2008
PMID: 18697819
National type 2 diabetes prevention programme in Finland: FIN-D2D.
Saaristo T, Peltonen M, Keinanen-Kiukaanniemi S, Vanhala M, Saltevo J, Niskanen L, Oksa H, Korpi-Hyovalti E, Tuomilehto J; FIN-D2D Study Group., Int J Circumpolar Health 66(2), 2007
PMID: 17515250
[Prevention of type 2 diabetes mellitus. Position paper of the National Action Forum for Diabetes Mellitus].
Hauner H, Landgraf R, Schulze J, Spranger J, Standl E; Nationale Aktionsforum Diabetes mellitus., Dtsch. Med. Wochenschr. 130(17), 2005
PMID: 15841418
The European perspective of type 2 diabetes prevention: diabetes in Europe--prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
Schwarz PE, Lindstrom J, Kissimova-Scarbeck K, Szybinski Z, Barengo NC, Peltonen M, Tuomilehto J; DE-PLAN project., Exp. Clin. Endocrinol. Diabetes 116(3), 2008
PMID: 18350480

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

PMID: 19232132
PubMed | Europe PMC

Suchen in

Google Scholar